hotspot -WSS

hotspot

author：focus 2025-09-01 15:21:05 - browse：53

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

WSS

'Null' research findings aren't empty of meaning. Let's publish them

H.R. 3 is the wrong path to lower drug costs

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Pfizer highlights cancer drugs it thinks could reignite investor interest

Medical device lobby: We're tired of waiting on Medicare coverage

ALS groups 'won't be played again' by the FDA, drug sponsors

focus

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

International team creates first chimeric human

Alkermes shareholders re

2 officers injured in shooting in Orlando, police say

In Memoriam: Notable people who died in 2023

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Dobbs anniversary: the lost opportunity of abortion as health care

In search for therapies for solid tumors, companies turn to claudin

Duchenne breakthrough therapy leaves behind pioneering families

Chris Christie meets with Zelenskyy during Ukraine trip

hotspot

It costs an awful lot of money to give away a kidney

Change Healthcare cyberattack outage could last weeks

Late stage cancers on the rise after pandemic delayed screenings

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Alnylam reports growth in sales of rare disease treatments

Clinical trials giant ICON acquires HumanFirst

Wikipedia

focus

leisure time

knowledge